HBME-1 immunostaining in reactive mesothelial versus metastatic adenocarcinoma cells in serous fluid
Background: The cytological diagnoses of serous effusions are usually made by routine cytomorphology with certainty. However, overlapping cases sometimes exist between reactive mesothelial and adenocarcinoma cells. We tried to evaluate the diagnostic utility of HBME-1 in distinguishing between react...
Saved in:
Main Authors: | Alireza Rahmani (Author), Mohsen Zahedi Dehghani (Author), Noushin Moghaddam Afshar (Author), Hamidreza Heidarian (Author), Reza Tahririan (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2011-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Utility of fibronectin in immuocytochemial differentiation of reactive mesothelial cells from metastatic malignant cells in serous effusions
by: Agarwal Chetna, et al.
Published: (2009) -
Utility of MOC-31 monoclonal antibody in differentiating metastatic adenocarcinoma cells and reactive mesothelial cells in effusion cytology
by: Bharat Patil, et al.
Published: (2018) -
Immunohistochemical distinction between mesothelial and adenocarcinoma cells in serous effusions: A combination panel-based approach with a brief review of the literature
by: Murugan Paari, et al.
Published: (2009) -
Expression of Calretinin, Marker of Mesothelial Differentiation, in Pancreatic Ductal Adenocarcinoma: A Potential Diagnostic Pitfall
by: Gokce ASKAN, et al.
Published: (2021) -
Lesion of Aggregated Monocytes and Mesothelial Cells: Mesothelial/Monocytic Incidental Cardiac Lesion
by: Hilal Erinanç, et al.
Published: (2013)